SCHEMBL4334327

SCHEMBL4334327

O=C(NCc1ccoc1)c1cc(F)c2[nH]nc(-c3cccc(F)c3)c2c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.43
HPGD P15428 2/20 0.42
TTK P33981 2/20 0.41
ROCK2 O75116 4/20 0.40
MAPK1 P28482 3/20 0.39
MAPK3 P27361 2/20 0.39
RET P07949 1/20 0.38
CSNK1D P48730 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KLKB1 P03952 1/20 0.38
AKR1C4 P17516 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
AURKA O14965 1/20 0.37
USP2 O75604 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4328099 0.87 MAPK1 (0.40) PARP1HPGDTTKMAPK1MAPK3
SCHEMBL4327002 0.84 HPGD (0.58) HPGDMAPK1ALDH1A1MEN1KMT2A
SCHEMBL4333984 0.83 PTAFR (0.51) TTKROCK2MAPK1MAPK3ALDH1A1
SCHEMBL4334573 0.82 TTK (0.55) PARP1HPGDTTKMAPK1ALDH1A1
SCHEMBL4345594 0.80 HPGD (0.42) HPGDTTKCSNK1DALDH1A1MEN1
SCHEMBL4340581 0.79 CSNK1D (0.42) HPGDTTKROCK2MAPK1MAPK3
SCHEMBL2866665 0.79 GABRA5 (0.48) HPGDMEN1KMT2A
SCHEMBL4334999 0.78 TP53 (0.41) HPGDMAPK1MAPK3CSNK1D
SCHEMBL4334123 0.76 ROCK2 (0.43) ROCK2MAPK1MAPK3
SCHEMBL2861586 0.76 MAP2K4 (0.56) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PARP1 2269/4885HPGD 1817/4885TTK 1201/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PARP1 2269/4885HPGD 1817/4885TTK 1201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.